Skip to main content
. 2018 Sep 6;12:2775–2783. doi: 10.2147/DDDT.S172068

Table 3.

Mean reductions in VAS scores for individual dyspeptic symptoms in the per-protocol population

Variable Nimesulide/pantoprazole (mean ± SD) Naproxen/esomeprazole (mean ± SD) Mean difference 95% CI P-value
Baseline vs Day 7
Nausea 20.41±3.06 16.55±3.16 3.77 −1.60 to 9.15 0.17
Abdominal discomfort/pain 28.71±3.02 29.76±2.92 1.05 −3.97 to 6.06 0.68
Epigastric burning 37.21±3.14 38.83±3.03 1.63 −3.59 to 6.84 0.54
Postprandial fullness 26.33±2.81 28.34±2.73 1.79 −2.98 to 6.56 0.46
Baseline vs Day 14
Nausea 20.26±3.14 22.41±3.03 2.26 −3.17 to 7.69 0.41
Abdominal discomfort/pain 32.28±2.92 34.20±2.81 1.93 −2.98 to 6.83 0.44
Epigastric burning 41.01±3.14 40.07±3.02 0.52 −5.55 to 4.52 0.84
Postprandial fullness 30.25±2.81 31.93±2.72 0.89 −3.96 to 5.73 0.72

Abbreviations: CI, confidence interval; SD, standard deviation; VAS, visual analog scale.